Clinical Trial Details

EORTC-22114-40111-GITCG-ROG

Back to Clinical Trials Database

Trial of preoperative therapy for gastric and esophagogastric junction adenocarcinoma. A randomized phase II/III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer.

Study documentation Publications

Trial Status Recruiting
Dates Date of activation: 13-Nov-2013
Data management at EORTC No
Design Phase 2-3
Randomized open label
Targeted Sample size EORTC Groups: 211 - All Groups: 752
Treatment Radiotherapy
Study Staff Karin Haustermans (Study Coordinator) , U.Z. Leuven - Campus Gasthuisberg, Leuven
Florian Lordick (Study Coordinator) , Universitaetsklinikum Leipzig UCCL-Krebszentrum, Leipzig
Catherine Fortpied (Statistician) , EORTC Headquarters, Brussels
Beatrice Fournier (Clinical Scientist) , EORTC Headquarters, Brussels
Julie Hermans (Regulatory Affairs Manager) , EORTC Headquarters, Brussels
Axelle Nzokirantevye (Data Manager) , EORTC Headquarters, Brussels
Katheline Vander Heggen (Clinical Operations Assistant) , EORTC Headquarters, Brussels
Christophe Verstegen (Clinical Operations Manager) , EORTC Headquarters, Brussels
Laurens Vinckier (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Type of cancer Gastric
Participating groups EORTC Gastrointestinal Tract Cancer Group
EORTC Radiation Oncology Group
Australasian Gastro-Intestinal Trials Group
Trans-Tasman Radiation Oncology Group Inc
Recruiting centers AZ Turnhout - Campus Sint Elisabeth (Turnhout, Belgium)
Asklepios Klinik Barmbek (Hamburg, Germany)
CHRU de Besancon - Hopital Jean Minjoz (Besancon, France)
Centre Hospitalier Regional Verviers (East Belgium) (Verviers, Belgium)
Hopital De Jolimont (Haine St Paul, Belgium)
Hopital Nord Franche-Comte - Site du Mittan (Montbeliard, France)
Hospital Clinico Universitario De Valencia (Valencia, Spain)
ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) (Badalona - (Barcelona), Spain)
ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) (L' Hospitalet De Llobregat, Spain)
Institut Sainte Catherine (Avignon, France)
Institut de Cancerologie Strasbourg Europe (formar Paul Strauss) (Strasbourg, France)
Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern (Muenchen, Germany)
Onkologie UnterEms, Leer-Papenburg-Emden (Leer, Germany)
Staedtisches Klinikum Braunschweig gGmbH (Braunschweig, Germany)
The Institute Of Oncology (Ljubljana, Slovenia)
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
Universitaet Rostock - Campus Schilingallee (Rostock, Germany)
Universitaetsklinikum Leipzig UCCL-Krebszentrum (Leipzig, Germany)
Universitaetsklinikum Tuebingen- Crona Kliniken (Tuebingen, Germany)
Universitair Ziekenhuis Antwerpen (Edegem, Belgium)
University Hospital Hradec Kralove (Hradec Kralove, Czech Republic)
Vall d'Hebron Institut Oncologia (Barcelona, Spain)
Centers to be activated Assistance Publique - Hopitaux de Paris - La Pitie Salpetriere (Paris, France)
CaritasKlinikum Saarbruecken St Theresia (Saarbruecken, Germany)
Policlinico Universitario A. Gemelli - Universita Del Sacro Cuore (Roma, Italy)
Rambam Health Care Campus, Oncology Institute (Haifa, Israel)
Protocol summary http://clinicaltrials.gov/ct/show/NCT01924819
NCT number NCT01924819
Financial Support Academic Fund